Patent 7723345 was granted and assigned to Lexicon Pharmaceuticals, Inc. on May, 2010 by the United States Patent and Trademark Office.
Compounds of formulae I and II are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and manage serotonin-mediated diseases and disorders: